Genetic testing plays a vital role in diagnosing and treating hematologic malignancies. It enables precise disease classification, prognostic stratification, and personalized treatment planning, guiding targeted therapies and minimizing adverse reactions. By detecting gene mutations and monitoring minimal residual disease (MRD), it helps assess relapse risks and improve patient outcomes.

Director Pang Wenjuan gave an example that in her recent consultation with an expatriate couple, in addition to explaining in detail the differences between Chinese and foreign IVF protocols, the hospital's Overseas Medical Department can also assist in providing fertility demand consulting and psychological assessment for fertility preservation (there are also overseas patients coming to China for treatment, such as a recent patient from Bangladesh who requested IVF at Jiahu